0000899243-20-000700.txt : 20200107 0000899243-20-000700.hdr.sgml : 20200107 20200107141229 ACCESSION NUMBER: 0000899243-20-000700 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200103 FILED AS OF DATE: 20200107 DATE AS OF CHANGE: 20200107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elsbree David B CENTRAL INDEX KEY: 0001292650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 20512986 MAIL ADDRESS: STREET 1: C/O ACME PACKET, INC. STREET 2: 100 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-03 0 0001492674 T2 Biosystems, Inc. TTOO 0001292650 Elsbree David B 101 HARTWELL AVENUE LEXINGTON MA 02421 1 0 0 0 Common Stock 2020-01-03 4 S 0 5316 1.16 D 91081 D Common Stock 10000 I By spouse The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2019, to cover payment of tax liability incident to the vesting of restricted stock units. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.14 to $1.17. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ John Sprague, Attorney-in-Fact 2020-01-07